期刊文献+

2020年山西省腹膜透析患者贫血的流行病学调查及相关因素分析

Epidemiological investigation and related factors analysis of anemia in peritoneal dialysis patients in Shanxi Province in 2020
原文传递
导出
摘要 目的对山西省腹膜透析(PD)患者的贫血进行流行病学调查并分析相关因素。方法筛选2020年全国血液净化病例登记系统的山西省PD患者病例,收集基本资料、透析状况、药物使用及实验室指标。血红蛋白(Hb)≥110 g/L视为治疗达标。结果2020年山西省PD患者血红蛋白(Hb)水平为(104.9±18.3)g/L,Hb总体达标率为40.2%。红细胞生成刺激剂使用率为97.1%,口服铁剂使用率为98.3%,静脉铁剂使用率为1.7%。男性Hb达标率高于女性;随年龄增长,Hb达标率呈增高趋势。与Hb达标患者相比,Hb未达标组患者的女性比例、透析龄、每周红细胞生成刺激剂剂量,持续不卧床PD患者每日透析液剂量、血肌酐及血磷较高,而平均年龄、职业稳定程度、血钙及血白蛋白较低(均P<0.05)。多因素Logistic回归分析显示,年龄<45岁、甲状旁腺激素>500 ng/L和血白蛋白<35 g/L为Hb未达标的风险因素。结论2020年山西省PD患者Hb≥110 g/L者占40.2%。年龄<45岁、甲状旁腺激素>500 ng/L、血白蛋白<35 g/L为Hb未达标的风险因素。加强年轻患者的健康宣教和慢病管理,调节好钙磷代谢,控制继发性甲状旁腺功能亢进及增强营养,可能有助于改善山西省PD患者的贫血情况。 Objective To perform epidemiological investigation on anemia in peritoneal dialysis(PD)patients in Shanxi Province in 2020 and analyze related factors.Methods Data of PD patients in Shanxi Province in 2020,registered in the Chinese National Renal Data System(CNRDS),were collected including basic information,dialysis status,drug use,and laboratory indicators.Hemoglobin(Hb)≥110 g/L was regarded as Hb level success.Results In 2020,the average Hb level of PD patients in Shanxi Province was(104.9±8.3)g/L,and the overall rate of Hb level success was 40.2%.The usage rate of erythropoietic stimulating agents(ESAs)was 97.1%.The usage rate of oral iron was 98.3%,while the usage rate of intravenous iron was 1.7%.The Hb level success rate was higher in the male than in the female patients.The Hb level success rate increased with age.Compared with the patients with Hb level success,those patients without Hb level success showed higher levels in the proportion of females,age of dialysis,weekly dose of ESAs,daily dialysate dose of patients with continuous ambulatory PD(CAPD),serum creatinine,and serum phosphorus,but lower levels in the average age,occupational stability,serum calcium,and serum albumin(all P<0.05).Multivariate logistic regression analysis showed that age<45 years old,parathyroid hormone>500 ng/L,and serum albumin<35 g/L were risk factors for the Hb level without success.Conclusion In Shanxi Province in 2020,40.2%PD patients had an Hb level of no less than 110 g/L.The risk factors for the Hb level to be less than 110 g/L included the age<45 years old,parathyroid hormone>500 ng/L,and serum albumin<35 g/L.Strengthening health education and chronic disease management for the young PD patients,well regulating calcium and phosphorus metabolism,controlling secondary hyperparathyroidism,and enhancing nutrition may be helpful to improve the anemia situation in the PD patients in Shanxi Province.
作者 樊佩琦 闫燕 李晓霞 武玲宇 郭罡玲 李静 王利华 Peiqi Fan;Yan Yan;Xiaoxia Li;Lingyu Wu;Gangling Guo;Jing Li;Lihua Wang(Department of Nephrology,Second Hospital of Shanxi Medical University;Center of Blood Purification Quality Control,Center of Medical Quality Control of Shanxi Provincial Health Commission,Taiyuan 030001,Shanxi Province,China)
出处 《中华肾病研究电子杂志》 2023年第3期121-126,共6页 Chinese Journal of Kidney Disease Investigation(Electronic Edition)
关键词 腹膜透析 肾性贫血 血红蛋白 红细胞生成刺激素 风险因素 Peritoneal dialysis Renal anemia Hemoglobin Erythropoietic stimulating agents Risk factors
  • 相关文献

参考文献4

二级参考文献67

  • 1陈香美,孙雪峰,蔡广研.重组人促红细胞生成素在肾性贫血中合理应用的专家共识[J].中国血液净化,2007,6(8):440-443. 被引量:109
  • 2McClellan WM, Flanders WD, Gutman RA. Variable mortality rates among dialysis treatment centers. Ann Intern Med 1992; 117: 332-336.
  • 3Hall YN, Jolly SE, Xu R Abrass CK, Buchwald D, Himmelfarb J. Regional differences in dialysis care and mortality among American Indians and Alaska Natives. J Am Soc Nephrol 2011; 22: 2287-2295.
  • 4Lopes AA, Bragg-Gresham JL, Goodkin DA, Fukuhara S, Mapes DL, Young EW, et al. Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res 2007; 16: 545-557.
  • 5Goodkin DA, Mapes DL, Held PJ. The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients? Sernin Dial 2001; 14:157-159.
  • 6Tentori F. Trends in medication use and clinical outcomes in twelve countries: results from the dialysis outcomes and practice patterns study (DOPPS). Contrib Nephrol 2008; 161: 48-54.
  • 7Zuo L, Wang M. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 2010; 74 Suppl 1: $20-$22.
  • 8Port FK, Pisoni RL, Bommer J, Locatelli F, Jadoul M, Eknoyan G, et al. Improving outcomes for dialysis patients in the international dialysis outcomes and practice patterns stud) Clin J Am Soc Nephrol 2006; 1: 246-255.
  • 9Goodkin DA, Bragg-Gresham JL, Koenig KC Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277.
  • 10Ravera M, Noberasco G, Weiss U, Re M, Gallina AM, Filippi A, et al. CKD awareness and blood pressure control in the primary care hypertensive population. Am J Kidney Dis 2011; 57: 71-77.

共引文献292

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部